Investigation announced for Investors in Applied Therapeutics, Inc. (NASDAQ: APLT) shares

An investigation was announced concerning potential securities laws violations by Applied Therapeutics, Inc. in connection with certain financial statements.

Investors who purchased shares of Applied Therapeutics, Inc. (NASDAQ: APLT), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Applied Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

New York based Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications.
On January 3, 2022, Applied Therapeutics, Inc disclosed that “[f]ollowing discussions with the FDA at the end of the year, the Company has decided to hold on submitting an NDA for AT-007 for treatment of Galactosemia pending additional discussions with the agency. Although the Galactosemia program had previously been discussed in the context of an NDA for Accelerated Approval based on reduction in galactitol, the FDA has now indicated that clinical outcomes data will likely be required for approval.”

Shares of Applied Therapeutics, Inc. (NASDAQ: APLT) declined from $10.13 per share on December 22, 2021, to as low as $3.60 per share on January 14, 2022.

Those who purchased shares of Applied Therapeutics, Inc. (NASDAQ: APLT) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.